Prone Partial Breast Irradiation (PBI): A Prospective Randomized Trial Comparing Five Versus Three Fractions

Brief description of study

If you have been diagnosed with Stage 0 or I breast cancer, also known as ductal carcinoma in situ (DCIS) or T1 breast cancer, you may qualify to participate in a clinical trial evaluating how well people tolerate two different doses of radiotherapy delivered within 1 week. Patients will be assigned randomly (like the flip of a coin) to one dose of radiotherapy or the other. The main goal of this study is to compare two different doses of radiation treatment in post-menopausal women with breast cancer and measure long-term effects of radiation fibrosis (thickening or firming of the breast that can be a side effect of radiotherapy) and other skin changes post-radiation treatment.

If you are registered as a volunteer, please login to the dashboard to send referrals.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.